| Literature DB >> 29175823 |
Neha Bhatnagar1, Georgina W Hall1.
Abstract
In this review, we outline the standard of care for children in the UK with the most common major bleeding disorder, haemophilia, and how exciting new developments in therapy have the potential for further improvements in quality of life and clinical outcome. The combination of comprehensive specialist medical care, safer factor concentrates, earlier introduction of prophylaxis and patient-specific education has allowed the current generation of patients with haemophilia to grow into adulthood with excellent joint function, pursuing full-time employment with a good quality of life. We are entering an exciting new phase in paediatric haemophilia as potentially life-changing products appear on the scene taking a step towards achieving better, easier and personalised prophylaxis. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: bleeding; haemophilia; products
Mesh:
Substances:
Year: 2017 PMID: 29175823 DOI: 10.1136/archdischild-2016-311018
Source DB: PubMed Journal: Arch Dis Child ISSN: 0003-9888 Impact factor: 3.791